Intensity Therapeutics, Inc.
INTS
$1.96
-$0.04-2.00%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
4/3/2025
-
Zacks Investment Research
3/13/2025
-
GuruFocus
3/13/2025
-
GuruFocus
3/13/2025
-
PR Newswire
2/15/2025
-
GuruFocus
2/14/2025
-
ETF Channel
1/28/2025
-
GuruFocus
1/28/2025
-
The Fly
1/28/2025
-
PR Newswire
1/13/2025
-
The Fly
1/13/2025
-
The Fly
1/10/2025
-
GuruFocus
1/10/2025
-
PR Newswire
12/13/2024
-
The Fly
12/12/2024
-
TipRanks Financial Blog
12/12/2024
-
The Fly
11/21/2024
-
GuruFocus
11/21/2024
-
Seeking Alpha - Healthcare
11/21/2024
-
PR Newswire
11/18/2024
-
TipRanks Financial Blog
11/18/2024
-
The Fly
11/13/2024
-
The Fly
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 13, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
203 221 7381
Address
1 Enterprise Drive
Shelton, CT 06484-4779
Shelton, CT 06484-4779
Country
Year Founded
Business Description
Sector
Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead...
more
